Guidelenines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society by Ansaloni, Luca et al.
REVIEW Open Access
Guidelenines in the management of obstructing
cancer of the left colon: consensus conference of
the world society of emergency surgery (WSES)
and peritoneum and surgery (PnS) society
Luca Ansaloni
1, Roland E Andersson
2, Franco Bazzoli
3, Fausto Catena
4, Vincenzo Cennamo
3, Salomone Di Saverio
5,
Lorenzo Fuccio
3, Hans Jeekel
6, Ari Leppäniemi
7, Ernest Moore
8, Antonio D Pinna
4, Michele Pisano
1*,
Alessandro Repici
9, Paul H Sugarbaker
10, Jean-Jaques Tuech
11
Abstract
Background: Obstructive left colon carcinoma (OLCC) is a challenging matter in terms of obstruction release as
well of oncological issues. Several options are available and no guidelines are established. The paper aims to
generate evidenced based recommendations on management of OLCC.
Methods: The PubMed and Cochrane Library databases were queried for publications focusing on OLCC published
prior to April 2010. A extensive retrieval, analyses, and grading of the literature was undertaken. The findings of the
research were presented and largely discussed among panellist and audience at the Consensus Conference of the
World Society of Emergency Surgery (WSES) and Peritoneum and Surgery (PnS) Society held in Bologna July 2010.
Comparisons of techniques are presented and final committee recommendation are enounced.
Results: Hartmann’s procedure should be preferred to loop colostomy (Grade 2B). Hartmann’s procedure offers no
survival benefit compared to segmental colonic resection with primary anastomosis (Grade 2C+); Hartmann’s
procedure should be considered in patients with high surgical risk (Grade 2C). Total colectomy and segmental
colectomy with intraoperative colonic irrigation are associated with same mortality/morbidity, however total
colectomy is associated with higher rates impaired bowel function (Grade 1A). Segmental resection and primary
anastomosis either with manual decompression or intraoperative colonic irrigation are associated with same
mortality/morbidity rate (Grade 1A). In palliation stent placement is associated with similar mortality/morbidity rates
and shorter hospital stay (Grade 2B). Stents as a bridge to surgery seems associated with lower mortality rate,
shorter hospital stay, and a lower colostomy formation rate (Grade 1B).
Conclusions: Loop colostomy and staged procedure should be adopted in case of dramatic scenario, when
neoadjuvant therapy could be expected. Hartmann’s procedure should be performed in case of high risk of
anastomotic dehiscence. Subtotal and total colectomy should be attempted when cecal perforation or in case of
synchronous colonic neoplasm. Primary resection and anastomosis with manual decompression seems the
procedure of choice. Colonic stents represent the best option when skills are available. The literature power is
relatively poor and the existing RCT are often not sufficiently robust in design thus, among 6 possible treatment
modalities, only 2 reached the Grade A.
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The majority of cases of acute colonic obstruction is
secondary to colorectal cancer. Up to 20% of patients
with colonic cancer present with symptoms of acute
obstruction [1-4]. Emergency surgery for acute colonic
obstruction is associated with a significant risk of mor-
tality and morbidity and with a high percentage of
stoma creation (either temporary or permanent)
[1,2,5,6]. Whereas right-sided colonic obstructions are
usually treated by one-stage resection with primary ana-
stomosis for all patients but the frailest [1], controversy
continues to revolve around emergency management of
obstructed left colon cancer (OLCC).
Indeed several options for OLCC are available (Figure 1):
1) loop colostomy (C) or loop ileostomy and subse-
quent resection (2 or 3 staged procedure)
2) primary resection with end colostomy: Hartmann’s
procedure (HP);
3) primary resection and anastomosis (PRA):
a. total/subtotal colectomy (TC)
b. segmental colectomy, (SC)
i. with intra-operative colonic irrigation (ICI)
ii. with manual decompression (MD)
4) endoscopic colonic stenting by self-expanding
metallic stents (SEMS):
a. palliation
b. bridge to surgery
The consensus conference aimed to evaluate available
literature to generate evidenced based recommendations
on management of OLCC. It must be stated, in advance,
that suggestions coming from this study are not substi-
tute of the clinical judgement.
Methods
The PubMed and Cochrane Library databases were
queried for publications focusing on OLCC published
prior to April 2010. The following Mesh headings were
used: ‘colonic neoplasm’, ‘intestinal obstruction’, ‘stents’,
‘colectomy’. Also, text terms were used in combination
such as: ‘colonic obstruction’, ‘colonic stents’, ‘Hart-
mann’so p e r a t i o n ’, ‘colonic irrigation’, ‘colostomy’,
‘anastomosis’.T h e r ew a sn ol a n g u a g er e s t r i c t i o n .T h e
‘Related Articles’ function in PubMed was used and the
references of the retrieved articles were reviewed. Initi-
ally the Chairman (AL) and the committee members
(BF, CV, LA, RA, TJJ) collaborated to the preparation of
a draft inclusive of preliminary statements. Subse-
quently, the Chairman, the committee members and
world renowned experts in the field met for a consensus
conference on OLCC during the 1
st World Congress of
World Society of Emergency Surgery and the IX Meet-
ing of Peritoneum and Surgery (PnS) Society (Bologna,
Italy, July 2010). During the consensus conference each
committee member presented a summary of evidence
available for each of the treatment options outlined in
Figure 1. The data available from literature review were
analyzed and graded according to the level of evidence
treatment options
for OLCC
1) simple colostomy with staged
managing for OLCC;
2) primary resection with end
colostomy (Hartmann·s operation);
3) one-stage resection
anastomosis:
a.Total/
subtotal
colectomy
b.
segmental
colectomy,
i. with intra-
operative
colonic
irrigation (ICI)
 ii. without intra-
operative colonic
irrigation (manual
decompression,
MD, only)
 4) colonic stenting. Palliation 
Bridge to surgery
Figure 1 Treatment Options for OLCC.
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(ACCP) systems (Table 1) [7,8]. Those presentations
served to launch a discussion on optimal management
of OLCC. Following exhaustive discussion the panel was
asked to agree on final recommendations.
The coordinators (FL, PM) merged the committee
preliminary statements with the observations and
recommendations from the panel, and had the responsi-
bility of summarizing the discussion on standards of
treatment for OLCC that are presented in this
manuscript.
Results
Loop colostomy (C) with staged procedure vs Hartmann’s
procedure (HP)
Loop colostomy is a historical component of the staged
therapeutic schema for OLCC. During the first stage,
the obstruction is managed by the colostomy. The sec-
ond stage takes place a few weeks later when the
tumour is resected and the colostomy is closed (two
stage procedure) or, alternatively, the colostomy can be
closed at a third stage. There is only one RCT study, by
Kromborg et al in 1995, comparing emergency colost-
omy with three stages procedure (58 patients) versus
HP (63 patients) for OLCC. The authors showed no dif-
ference in terms of mortality (8/58 vs. 8/63 patients)
and morbidity rate, recurrence rate and cancer specific
survival; the overall length of hospital stay was shorter
in the resection group [9]. However this RCT has some
important limitations due to methodological flaws: no
prior sample size estimation; a 15-year accrual period;
procedures being performed by 36 attending and train-
ing surgeons; incomplete follow up; heterogeneous
underlying pathology (with non-malignant strictures
accounting for 14% of cases).
Previously Fielding et al. in 1979 published a prospec-
tive non-randomised study (PNRS) which showed the
same mortality rate for both groups [10]; however the
study was affected by strong bias selection. A Cochrane
systematic review in 2008 by De Salvo rt al, compared
staged procedure vs. primary resection, and found simi-
lar mortality with either strategy [11]. It should be
noted that the Kronborg study was excluded for metho-
dological weaknesses. In theory, several benefits might
be associated with creation of a loop colostomy: it pro-
vides colonic decompression; minimizes surgical trauma;
reduces the risk of contamination from unprepared
bowel; allows staging and multidisciplinary evaluation
prior to definitive treatment.
Our literature review reveals that C does not provide
any short- or long-term benefit over the HP whereas
the multiple operations are associated with longer over-
all hospital stay: 49 days in group C vs. 35 days in HP
g r o u p( p=0 . 0 1 ) ;f i n a l l yt h es t a g e da p p r o a c hs h o w sa
not significant tendency to expose the patient to a
higher cumulative morbidity as a result of multiple
operations[9].
Recommendation: HP should be preferred to C for
OLCC, since C appears to be associated with longer
overall hospital stay and need for multiple operations
Table 1 Grades of Recommendations according to the American College of Chest Physicians (ACCP) 78
Grade of
recommendation
Clarity of
risk/
benefit
Methodological strength of supporting evidence Implications
1A Risk/
benefit
clear
Randomized controlled trials (RCTs) without important
limitations
Strong recommendation, can apply to most patients in
most circumstances without reservation
1B Risk/
benefit
clear
RCTs with important limitations (inconsistent results,
methodological flaws)
Strong recommendations, likely to apply to most patients
1C + Risk/
benefit
clear
No RCTs but RCT results can be unequivocally
extrapolated, or overwhelming evidence from
observational studies
Strong recommendation, can apply to most patients in
most circumstances
1C Risk/
benefit
clear
Observational studies Intermediate strength recommendation; may change
when stronger evidence available
2A Risk/
benefit
unclear
RCTs without important limitations Intermediate strength recommendation, best action may
differ depending on circumstances or patients’ or societal
values
2B Risk/
benefit
unclear
RCTs with important limitations (inconsistent results,
methodological flaws)
Weak recommendation, alternative approaches likely to be
better for some patients under some circumstances
2C Risk/
benefit
unclear
Observational studies Very weak recommendations; other alternatives may be
equally reasonable
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(Grade of recommendation 2B).
Advice: the role of staged procedure, with preference
at the two stages operation, should be considered (a) in
a clinical situation where a surgical approach like
“damage control” could be applied as happens in trauma
scenario (b) when neoadjuvant multimodality therapy
can be expected, or c) unresectable disease.
Hartmann’s procedure (HP) vs. primary resection and
anastomosis (PRA)
There are no RCTs comparing HP and PRA; thus
neither grade A and B evidence are available.
In 2004 Meyer et al by a prospective non randomized
multicenter study compared, in emergency scenario, 213
patients undergoing HP to 340 patients undergoing PRA
for OLCC. The mortality rate in the case of palliation
for HP and PRA respectively was 33% vs. 39% and in
case of curative intent for HP and PRA respectively
7,5% vs. 9,2%, however both of them without statistical
difference; also the morbidity rate was not significantly
different among groups; finally the HP was the most fre-
quent surgical option [6]. The authors made a substan-
tial effort in planning the study, collecting and analyzing
data, however the number of participating institutions
was very high (309) and heterogeneous spanning from
regional to university hospitals. Finally among prospec-
tive non randomized and retrospective studies the rates
of anastomotic leak in patients with OLCC treated with
PRA range from 2,2% to 12% [5,6,12-14], which are
similar to those reported for elective surgery ranging
from 1,9% to 8% [15-18].
Furthermore our literature review suggests that HP
might be associated with worse long-term outcomes.
Villar et al. in 2005 published a prospective non rando-
mized study comparing HP in 20 patients to PRA in 35
patients divided into ICI/SC or TC: they reported 5-year
overall survivals of 38% and 41-45% for HP and PRA
(divided into subgroups) respectively; however this dif-
ference was likely the result of selection bias as anasto-
mosis was likely avoided in higher-risk patients [12,14].
The absence of anastomosis makes HP a technically
easier operation and obviously eliminates the risk of
colon dehiscence in a already complex scenario such as
occurs in high grade obstruction: thus HP still remains
an option also suitable by less experienced and non-
specialist surgeons. The main disadvantages of HP is
clearly the need for a second major operation to reverse
the colostomy, which will be also associated with a risk
of anastomotic dehiscence similar to PRA. Furthermore,
it is somewhat disappointing to observe that the stoma
reversal rate is only 20% in those patients with colon
cancer [12,19]. PRA offers the advantages of a definite
procedure without need for further surgery. Its main
disadvantages are related to the increased technical chal-
lenge and to the potential higher risk of anastomotic
leakage that occurs in the emergency setting.
Although PRA appears, at least in theory, more
appealing than HP in OLCC, several parameters (patient
and surgeon related) should be taken in consideration
prior to choose the surgical procedure [5,14,20].
Risk stratification is at the base of patient selection.
The Association of Coloproctology of Great Britain and
Ireland (ACPGBI) study of large bowel obstruction
caused by colorectal cancer identified four important
predictors of outcome - age, ASA grade, operative
urgency, and Dukes’ stage [5]. Similar results were
shown by other studies [14,20]. Recent large studies
demonstrated that mortality rate after PRA of obstruc-
tive right colon cancer is higher than mortality after
PRA for OLCC [5,14,21], whereas one study did not
show any difference [22]. This findings could be
explained by the fact that almost all patients with right-
sided obstruction are treated by one stage resection and
anastomosis, whereas patients with OLCC are carefully
selected according to risk.
Keeping in mind these considerations the HP could be
appropriate for patients deemed to be at high risk.
Moreover the same considerations could explain the
results of a questionnaire survey of American Gastroin-
testinal Surgeons in 2001 who responded that 67%
would perform HP and 26% a simple colostomy in the
high-risk patient [23]. Otherwise we should assume a
lack of adherence to the literature evidence in the clini-
cal practice or difficulty in changing from surgical
tradition.
The experience and subspecialty of surgeon seems to
be a primary factor in the choice of anastomosis or end
colostomy. It has been shown that primary anastomosis
is more likely to be performed by colorectal consultants
rather than general surgeons, and by consultants rather
than unsupervised trainees [20]. The ACPGBI study has
shown that the mortality rate following surgery was
similar between ACPGBI and non-ACPGBI members
[5]. This result can be challenged as the study was done
on a voluntary basis. The Large Bowel Cancer Project
showed that registrars had a higher mortality rate than
consultants after primary resection for obstruction in
the late 1970 s, and this result has remained unchanged
20 years later in the Zorcolo study [1,20]. Other studies
have also shown that unsupervised trainees had signifi-
cantly greater morbidity, mortality and anastomotic
dehiscence rates [10,24].
Recommendation: HP offers no overall survival benefit
compared to segmental colonic resection with primary
anastomosis in OLCC (Grade of recommendation 2C+);
HP should be considered in patients with high surgical
risk (Grade of recommendation 2C)
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subtotal colectomy (TC) vs. segmental colectomy (SC)
T h e r ei so n l yo n eR C T ,w r i t eo u tS C O T I As t u d yg r o u p
(Subtotal Colectomy versus on Table Irrigation and
Anastomosis) in 1995, that compared the TC (47 patients)
vs. SC (44 patients) and ICI. There were no differences in
mortality, overall morbidity and rates of single complica-
tions (superficial and deep surgical site infections, anasto-
motic leakage). In regard of long-term outcomes, patients
undergoing TC were noted to have a statistically higher
number of daily bowel movements compared to ICI/SC.
The authors concluded that SC following ICI should be
therefore preferred to TC [25].
Another non-randomised study comparing the two
techniques did not show any difference in mortality but
showed significantly more surgical postoperative compli-
cations in the ICI group and in particular superficial
surgical site infections [26].
TC as a one-stage resection anastomosis in OLCC
allows the surgeon to encompass a massively distended
and faecal-loaded colon [27,28]; moreover the proximal
colon dilatation makes difficult the detection of synchro-
nous cancer and so TC could bypass the need for further
operation especially in severely ill patients. However we
can’t extend the use of TC as a prophylaxis of future
malignancy outside hereditary tumours syndromes [27].
In the 1980 s, segmental colectomy with ICI was sug-
gested as an alternative operation. It has the benefit of
making an anastomosis on a prepared bowel and
preserving the normal colon. The main concerns are the
prolonged operative time, the risk of spillage and contami-
nation, and the need for increased expertise [25].
Absolute indications for STC in OLCC are right colon
ischemia, cecal serosa tears or perforation, and synchro-
nous proximal malignant tumours which occur in 3 to
10% of cases [27]; it is a one stage radical oncological
resection with advantages to treat synchronous proximal
tumours, prevent metachronous cancer, to avoid stoma
creation and to remove the colon as a septic content; but
the major disadvantages are resection of healthy colon,
resulting in poor functional results with many patients
complaining of diarrhoea afterwards [25,27,28].
Recommendation: TC for OLCC (without cecal perfora-
tion or evidence of synchronous right colonic cancers)
should not longer be preferred to SC with ICI, since the
two procedures are associated with same mortality/
morbidity, while TC is associated with higher rates
impaired bowel function (Grade of recommendation 1A).
Primary resection and anastomosis (PRA): Segmental
colectomy (SC) with intraoperative colonic irrigation (ICI) vs.
Segmental colectomy (SC) with manual decompression (MD)
Lim et al in 2005 published the only RCT comparing
ICI (24 patients) with MD (25 patients) in OLCC. They
concluded that MD is a shorter and simpler procedure
than ICI, and offers similar results in terms of mortality,
morbidity or anastomotic leak rates, but the study was
underpowered [29].
On average, the ICI increases duration of surgery by
an hour, although this time can improve with increasing
experience. To overcome the problems of ICI, various
studies suggested segmental resection and primary ana-
stomosis with MD only, as an safe alternative [29-32].
This idea was supported by various RCTs comparing
mechanical bowel preparation, with no preparation in
elective open colonic surgery.
The results were separately examined in a Cochrane
systematic review of 9 RCTs [15] and in a metaanalysis
of 7 RCTs [33]. Both studies concluded that there is no
convincing evidence that mechanical bowel preparation
is associated with reduced rates of anastomotic leakage
after elective colorectal surgery.
Finally in 2009 Kam et al published a systematic
review on ICI vs. MD in left-sided colorectal emergen-
cies: they included 1 RCT, 1 prospective comparative
trial and 5 prospective descriptive case series and con-
cluded that, although the power of studies is poor and
large-scale prospective randomized trial is desirable, no
statistical significance could be shown between the two
procedures [34].
Recommendation: during segmental resection and pri-
mary anastomosis for OLCC (without cecal perforation
or evidence of synchronous right colonic cancers), either
MD or ICI can be performed as the two techniques are
associated with same mortality/morbidity rate. The only
significant difference is that MD is a shorter and simpler
procedure. Either procedure could be performed,
depending of the experience/preference of the surgeon
(Grade of recommendation 1A).
Endoscopic Colonic Stents (SEMS)
Colonic stents were introduced in the 1990 s and have
been used for palliation or as a bridge to surgery:
following release of the obstruction with an endoscopic
stent the patient is properly staged and offered multidis-
ciplinary treatment and eventually elective or semi-
elective surgery [35].
A) Palliation: endoscopic colonic stents (SEMS)
vs. colostomy (C)
There are three RCTs comparing colostomy vs. SEMS
for palliation of malignant colonic obstruction [36-38].
Xinopulos et al in 2004 randomized 30 patients. In
the SEMS group placement of the stent was achieved
in 93.3% (14/15 pt); there was no mortality. In 57%
(8/14) of patients in which the stent was successfully
placed, colonic obstruction was permanently released
(i.e. until death). Mean survival was 21,4 month in
SEMS group and 20,9 months in C group. Mean
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cantly higher in group C: 28 days vs. 60 days. This study
presented several limitations, and the small sample size
might have limited the ability to discern differences
between groups [36]
Fiori et al in 2004 randomized 22 patients to either C
or SEMS: mortality was 0% in both groups, morbidity
was similar. SEMS group had shorter time to oral
intake, restoration of bowel function, and hospital stay.
This study was also limited by the small simple size and
by the lack of follow up [37]
The Dutch Stent-in I multicenter RCT was planned to
randomized patients with incurable colorectal cancer to
SEMS or surgery: the study was terminated prematurely
after enrolling 21 patients because four stent-related
delayed perforations resulting in three deaths among 10
patients in the SEMS group. There are no clear explana-
tion for such a high perforation rate; the authors
pointed out that limited safety data existed fort he stent
used in their study (WallFlex, Boston Scientific Natick,
MA) [38]. Indeed, subsequent studies of Wallflex stent
for colonic obstruction reported a perforation rate of
about 5% [39-42] which is in line with what commonly
observed with other stents [42].
The feasibility, safety, and efficacy of SEMS have been
analyzed by retrospective studies. There are four
systematic reviews analysing the outcome of SEMS for
large bowel obstruction with the Sebastian study being
the most complete and focused one [43-46]. He
retrieved 54 studies with a total of 1198 patients and the
median rates were: technical success 94%, the clinical
success 91%, the colonic perforation 3,76%, the stent
migration 10%, the re-obstruction 10%, stent-related
mortality 1% [44]. These studies have shown that
colonic stenting is a relatively safe technique with high
success rates.
The influence of colonic stents on oncologic outcomes
has been questioned but no exhaustive answer is avail-
able. Indeed, several studies suggested that primary
tumour resection with palliative intent, would prolong
survival in patients with stage IV colorectal cancer
[47,48]. However the power of these retrospective stu-
dies is poor due to the study design, no uniform adju-
vant therapies among groups, and the bias to compare
unresectable stage IV cancer patients with resectable
stage IV cancer patients.
On the other hand, several comparative, retrospective
studies did not show any significant difference in term
of overall survival after 3 and 5 years of follow up,
between emergency surgery and stent placement [49,50].
Colonic stents have an attractive role in a multimodal-
ity approach to obstructive colon cancer; however close
clinical observation is required: for example there is one
literature report that colonic stent may increase the risk
of colon perforation in patients who are candidates for
bevacizumab: thus according to authors alternative
treatments to SEMS in these patients should be consid-
ered [51].
Recommendation: in facilities with capability for stent
placement, SEMS should be preferred to colostomy for
palliation of OLCC since stent placement is associated
with similar mortality/morbidity rates and shorter hospi-
tal stay (Grade of recommendation 2B).
Advice: authors cautiously suggest to consider alterna-
tive treatments to stent in patients eligible for further
bevacizumab-based therapy
B) Bridge to surgery: endoscopic colonic stents and planned
surgery vs. emergency surgery
Cheung et al. recently published a RCT comparing
endolaparoscopic approach (24 pts) vs. conventional
open surgery (24 pts). In patients who were randomized
to the endolaparoscopic group, an SEMS placement for
colon decompression was attempted within 24-30 hours
from admission and an elective laparoscopic-assisted
colectomy was performed within two weeks following
SEMS placement. Patients who were randomized to the
open surgery group underwent emergency HP or TC
with ICI on the same day of admission. Over a 3-years
period, 50 patients were enrolled and 48 were available
for the final analysis (24 in the open surgery group and
24 in the endolaparoscopic group). Overall, only 6 of11
patients undergo HP had subsequent reversal; PRA was
conducted in 13 patients all but two without covering
stoma; two patients experienced anastomotic leak (2 out
of 11, 18,8%) requiring end colostomy and one of these
had subsequent reversal; thus 1-stage operation was per-
formed successfully in 38% and 75% avoided a perma-
nent colostomy. Colon decompression by SEMS was
achieved in 83% of patients while the 17% had HP At
the time of planned surgery, 67% of patients in the
endolaparoscopic group had successful 1-stage opera-
tions performed and the 4 remaining patients had
diverting ileostomy (33%); finally in the endolaparo-
scopic group no one was given a permanent stoma.
Furthermore, patients randomized to the endolaparo-
scopic group compared to emergency surgery had signif-
icantly greater successful 1-stage operation (16 vs.9;
p = 0,04), less cumulative blood loss (50 ml vs. 200;
p = 0,01), less wound infection (2 vs. 8; p = 0,04),
reduced incidence of anastomotic leak (0 vs.2; p = 0,045),
and greater lymph-node harvest (23 vs.11; p = 0,05).
Cheung and colleagues suggest that colon decompres-
sion provides time for resuscitation, adequate staging,
bowel preparation and safer, minimally-invasive elective
resection. Indeed, the rate of primary anastomosis is
twice that following emergent surgery, and the stoma
rate and the postoperative complications are signifi-
cantly reduced [52].
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planned surgery with emergency surgery (HP, or PRA).
Martinez-Santos in a prospective non-randomised study
comparing 43 patients in the SEMS group with 29
patients in emergency surgery group reports a 95% tech-
nical success rate of SEMS; however only 26 patient in
the SEMS group had a further surgical operation: at the
time of planned surgery for SEMS the comparison of
median rate between SEMS vs. emergency surgery
shows: primary anastomosis was 84,6% vs. 41,4% with p
= 0,0025; morbidity was 40% vs.62% p = 0,054; ICU stay
was 0,3 vs.2,9 days p = 0,015; reintervention was 0% vs.
17% p = 0,014; mortality was 9% vs. 24% however with-
out reaching statistical significance [53]. However the
study is somewhat confusing because it include also a
large population of palliative SEMS (14) and the two
population in SEMS are sometime mixed and then com-
pared to emergency surgery group. Similar results are
reported also in less robust retrospective studies [50,54].
Tinley in 2007 performed a meta-analysis of non-
randomised studies that compared SEMS and open
surgery for malignant large bowel obstruction: SEMS
was attempted in 244 out of 451 patients (54,1%) with a
success rate of 92,6%; mortality occurred in 14 (5,7%) in
SEMS and in 25 (12,1%; p = 0,03) in emergency surgery
[55]. This metaanalysis however was likely impaired by
the heterogeneity of studies, since both patients stented
for palliation or as a bridge to surgery were included. In
this meta-analysis mortality rate for stenting (5.7%) was
much higher than the 0.6% rate reported in a large sys-
tematic review [45]
Little is known on oncologic outcomes of using SEMS as
a bridge to elective surgery. A recent paper recommended
that surgery should be scheduled shortly after stent inser-
tion because the risk of tumour seeding from perforation
and dislocation of stent [56]. However selection bias of
indication and timing of stenting could explain the high
level of complications reported with SEMS and conse-
quently the advice of authors regarding long-term survival
[57]. Finally there is no study available comparing survival
in SEMS versus other surgical options.
The cost effectiveness of SEMS is an important para-
meter as stents are very expensive. It is thought that
their cost is offset by the shorter hospital stay and the
lower rate of colostomy formation. Two decision analy-
sis studies from the US and Canada calculated the cost-
effectiveness of two competing strategies - colonic stent
versus emergency primary resection for OLCC [58,59]
Both concluded that colonic stent followed by elective
surgery is more effective and cost efficient than emer-
gency surgery. A small retrospective study from the UK
in 1998 showed that palliative stenting compared to sur-
gical decompression allows saving a mean of £1769,
whereas the stenting as a bridge to elective resection vs.
emergency HP followed by elective reversal saved a
mean of £685 [60]. A RCT from Greece comparing
SEMS and colostomy for palliation of patients with
inoperable malignant partial colonic obstruction showed
very small difference in the costs, with the stent group
being 6.9% (132 euros) more expensive per patient [36].
Another study from Switzerland reported SEMS to be
19.7% less costly than surgery [61]. None of these
studies incorporated the hidden costs of stoma bags
used in the community. Although stents seem to be cost
effective, results are difficult to compare because costs
calculations vary in different health care systems, costs
differ for palliation and bridge to surgery, and the cost
of stents is likely to decrease over time.
Recommendation: SEMS should be used as a bridge to
elective surgery in referral centre hospitals with specific
expertise and in selected patients mainly as their use
seems associated with lower mortality rate, shorter hos-
pital stay, and a lower colostomy formation rate (Grade
of recommendation 1B).
Conclusions
This consensus conference aimed to analyze the avail-
able scientific evidence on treatment modalities for
OLCC and how this is implemented in clinical practice.
The goal of the authors was to offer practical and scien-
tifically supported suggestion to manage OLCC.
The committee made every effort to collect and classify
the best available scientific evidence on treatment of
OLCC (Table 2). Subsequently, the audit and panel discus-
sion played a pivotal role in the statement declarations.
All the participants at consensus conference agree that
the literature power is relatively poor and the existing
R C Ta r eo f t e nn o ts u f f i c i e n t l yr o b u s ti nd e s i g nt h u s ,
among 6 possible treatment modalities, only 2 reached
the Grade A.
To help in decision making the authors wish to
suggest surgeons to consider 3 further key points
approaching OLCC: patient stratification according to
the ACPGBI rules; clinical environment; surgeon skill.
The target as usual is to offer the best option for the
patient; starting from this point of view also historical
surgical option could still play a valid role. The staged
procedure, with preference to the two stages, should be
reserved when multimodality therapy is expected or in
case of “dramatic” scenarios.
PRA with manual decompression is a safe option and
appears to be associated with best outcomes. HP might
still have a role in patients at high risk for anastomotic
d e h i s c e n c e .T Ci sa na p p e a l i n go p t i o ni nc a s eo fs y n -
chronous polyps or cancer and/or impending or actual
perforation of the right colon. SEMS represent a valu-
able option both for palliation and as a bridge to elective
surgery. Obviously high clinical and technical expertise
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Page 7 of 10is mandatory to safely and successfully treat colonic
obstruction by stents: due to this consideration routine
use in practice is still limited.
H o w e v e rw es t r o n g l ys u p p o r ta judicious application
of the procedure and encourage increased use of stents
after adequate training in referral hospitals with a goal
of further testing this modality.
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